TLR3-Stimulated Dendritic Cells Up-regulate B7-H1 Expression and Influence the Magnitude of CD8 T Cell Responses to Tumor Vaccination
- 15 September 2009
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 183 (6), 3634-3641
- https://doi.org/10.4049/jimmunol.0900974
Abstract
Agonists of TLR have been explored as vaccine adjuvants for tumor immunotherapy. However, their immunological consequences are not fully understood. Although TLR signaling increases the functional potential of dendritic cells (DCs) for priming T cells, coinduction of potentially negative immunoregulatory capacities may impair effector T cell generation. We examined the expression and function of B7 family costimulatory molecules on DCs after activation with the TLR3 agonist, polyinosinic:polycytidylic acid. We demonstrated that polyinosinic:polycytidylic acid consistently up-regulated both B7-2 and B7-H1 molecules on resident, migratory DCs from spleen and lymph nodes. Depletion or blockade of B7-H1 on activated DCs increased the magnitude of effector CD8 T cell expansion. DC-based or protein-based tumor vaccines, in combination with B7-H1 blockade, induced strong effector CD8 T cell responses, resulting in protective immunity against newly established tumors. Our studies suggest that TLR3 signaling has the potential to up-regulate both positive and negative coregulatory molecules on APCs. Selective blockade of negative regulatory molecules in combination with TLR3 agonist may be an effective strategy for increasing the efficacy of tumor vaccines.Keywords
This publication has 51 references indexed in Scilit:
- Batf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell ImmunityScience, 2008
- Adjuvants targeting innate and adaptive immunity synergize to enhance tumor immunotherapyProceedings of the National Academy of Sciences of the United States of America, 2008
- Tumor-Induced Immune Suppression ofIn vivoEffector T-Cell Priming Is Mediated by the B7-H1/PD-1 Axis and Transforming Growth Factor βCancer Research, 2008
- Selective suicide of cross-presenting CD8 + dendritic cells by cytochrome c injection shows functional heterogeneity within this subsetProceedings of the National Academy of Sciences of the United States of America, 2008
- The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccineProceedings of the National Academy of Sciences of the United States of America, 2008
- TLR-mediated induction of negative regulatory ligands on dendritic cellsJournal of Molecular Medicine, 2008
- Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2–MyD88 signal pathway in dendritic cells and enhances Th2 immune responsesThe Journal of Experimental Medicine, 2008
- TLR signalingCell Death & Differentiation, 2006
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2European Journal of Immunology, 2002